Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
GPAM - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
VPS53 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATPAF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GLTSCR1L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
STAMBP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAP7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC101929819 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
LOC101928826 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SOS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MICAL3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
VIL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GUSBP5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HOXC13 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MBNL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARFGEF2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
USP49 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ENDOV - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on